The stock of Braskem S.A. (NYSE:BAK) decreased by -$0.37 on Wednesday to $9.07, down -3.92 percent. The last five days have seen an average of 590,395 shares of common stock traded. 7 times new highs were reached in the current year, with a fall of -$0.18. The average number of shares traded over the last 20 days was 671,534, while the average volume over the last 50 days totaled 833,597.
BAK stock appreciated 1.91% since last month. On 08/29/23, the company’s shares reached a one-month low of $8.63. The stock touched a high of $14.51 on 06/20/23, after rallying from a low of $6.26 in 52 weeks. The price of BAK stock has declined by -1.41% or -$0.18 this year, reaching a new high 7 times. Still, the stock price is down -37.49% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
Beta for the stock is 1.73. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 0.23, the price-to-book (PB) ratio of 2.43.
Financial Health
For the three months ended June 29, Braskem S.A.’s quick ratio was 0.90, while its current ratio was 1.50, indicating its inability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 6.67, and the total debt to equity ratio is 7.15. As far as profitability goes, gross margin for the trailing twelve months is 4.40% percent. Braskem S.A.’s EBITDA margin for the year ended June 29 was 11.20%, whereas its operating margin stood at -2.80% for the same period. Based on annual data, it had gross profit of $2.2 billion and revenue of $18.7 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. BAK’s return on assets (ROA) during the last 12 months has been -3.80%. There was a 5.80% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -43.80%.
Earnings Surprise
According to Braskem S.A.’s quarterly financial report for the quarter that ended June 29. A lower net income was reported in the quarter under review than the previous quarter. It was predicted that Braskem S.A.’s quarterly earnings would be -$0.39, but it ended up being -$0.45, beating the consensus by 13.30%. EBITDA was -$56.21 million for the quarter. At the end of Braskem S.A.’s most recent quarter ended June 29, its liabilities totaled 16.42 billion, while its total debt was $54.09 billion.
Technical Picture
Here’s a quick look at Braskem S.A.’s (BAK) price momentum from a technical perspective. As of 19 September, the RSI 9-day stood at 43.15%, suggesting the stock is Neutral, with a 47.67% historical volatility rate.
The stochastic %K and %D were 52.80% and 55.85% respectively, while the average true range (ATR) was 0.38. Based on the 14-day stochastic reading of 18.42%, the RSI (14) reading is 44.02%. On the 9-day MACD Oscillator, the stock is at 0.03, and the 14-day reading is at 0.07.
Analyst Ratings
Braskem S.A. (NYSE: BAK) was downgraded by UBS to a a Sell rating in its latest research report. The stock was previously rated as a a Neutral. Analysts have assigned Braskem S.A. (BAK) an Overweight rating. BAK is a stock that is recommended for selling by 1 brokerage firm, while 4 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 5 others recommend it as a buy.
What is BAK’s price target for the next 12 months?
The current consensus forecast for the stock is between $8.16 and $16.39, with a median target price of $14.27. In analyzing these forecasts, the average price target given by analysts for Braskem S.A. (BAK) is $13.04.
